|Bid||0.00 x 1100|
|Ask||0.00 x 1100|
|Day's Range||45.90 - 46.83|
|52 Week Range||30.93 - 47.60|
|Beta (5Y Monthly)||0.51|
|PE Ratio (TTM)||33.75|
|Earnings Date||Feb 14, 2023|
|Forward Dividend & Yield||0.84 (1.78%)|
|Ex-Dividend Date||Dec 29, 2022|
|1y Target Est||N/A|
Lincoln, Nebraska, Feb. 03, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 14, 2023, to shareholders of record as of the close of business on Friday, March 31, 2023. For more than 40 years, NRC Health has been committed to achieving Human Understanding and bringing healthcare organizations closer to their customers than ever before by ill
Lincoln, Nebraska, Jan. 30, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2022 fourth quarter earnings conference call on Wednesday, February 15, 2023. The Company’s results for the 2023 fourth quarter will be released after the close of the market on Tuesday, February 14, 2023. The live broadcast of National Research Corporation’s conference call will begin at 11:00 a.m. Eastern Time on February 15, 2023.
National Research ( NASDAQ:NRC ) Third Quarter 2022 Results Key Financial Results Revenue: US$37.7m (flat on 3Q 2021...